Hi JT, Not holding any of those hoties. My best performer is SNCR. I am also holding CALD, which has gone nowhere yet, but 2008 earnings are estimated at $0.21 a share, with a $12.50 target price, currently at $5.25.
IDMI is at about $1.00, and got an extension re: approval of "Junovan" by EU to January. Any thoughts on what might happen? Either IDM is finding a partner to market "Junovan" in Europe, which would mean approval and about $4 to $5+ a share, or, if no EU approval, finding some way to survive as a company. I am holding my breath that it is the former. January should be interesting.
Hey, thanks for note and Best Wishes this Holiday Season and Happy New Year 2008!
Cheers, Bow